Abstract
Jeannette Hammond, PA-C, of the Seattle Cancer Care Alliance comments on major research presented at the ASCO Annual Meeting: a study addressing an unmet need in the metastatic urothelial cancer setting, a study showing no benefit from an adjuvant therapy, and the results of a study to institute a specialized pain management program. Coverage is provided by The ASCO Post.
